Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372:1734–1747. https://doi.org/10.1056/NEJMra1402225

Article  PubMed  Google Scholar 

Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7:86. https://doi.org/10.1038/s41572-021-00321-x

Article  PubMed  Google Scholar 

Temiz P, Weihl CC, Pestronk A (2009) Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 278:25–29. https://doi.org/10.1016/j.jns.2008.11.010

Article  PubMed  Google Scholar 

Blume G, Pestronk A, Frank B, Johns DR (1997) Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy. Brain 120(Pt 1):39–45. https://doi.org/10.1093/brain/120.1.39

Article  PubMed  Google Scholar 

Needham M, Mastaglia FL (2007) Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 6:620–631. https://doi.org/10.1016/S1474-4422(07)70171-0

Article  PubMed  Google Scholar 

Acosta IJ, Hofer M, Brady S (2022) Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathy. Neuromuscul Disord 32:441–444. https://doi.org/10.1016/j.nmd.2022.03.005

Article  PubMed  Google Scholar 

Lauletta A, De Carolis L, Teresi V, Fionda L, Leonardi L, Ceccanti M et al (2023) Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause? Neurol Sci 44:4525–4529. https://doi.org/10.1007/s10072-023-07035-w

Article  PubMed  Google Scholar 

Alhatou MI, Sladky JT, Bagasra O, Glass JD (2004) Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology. J Mol Histol 35:615–619. https://doi.org/10.1007/s10735-004-2194-6

Article  PubMed  Google Scholar 

Varadhachary AS, Weihl CC, Pestronk A (2010) Mitochondrial pathology in immune and inflammatory myopathies. Curr Opin Rheumatol 22:651–657. https://doi.org/10.1097/BOR.0b013e32833f108a

Article  CAS  PubMed  Google Scholar 

Siepmann T, Tesch M, Krause F, Illigens BM-W, Stoltenburg-Didinger G (2013) Polymyositis with cytochrome C oxidase negative fibers–a pathological and clinical challenge. Ann Diagn Pathol 17:183–6. https://doi.org/10.1016/j.anndiagpath.2012.10.004

Article  PubMed  Google Scholar 

Papadimas GK, Kokkinis C, Xirou S, Chrysanthou M, Kararizou E, Papadopoulos C (2019) Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature. Rheumatol Int 39:1459–1466. https://doi.org/10.1007/s00296-019-04314-8

Article  PubMed  Google Scholar 

Kleefeld F, Uruha A, Schänzer A, Nishimura A, Roos A, Schneider U et al (2022) Morphological and molecular patterns of polymyositis with mitochondrial pathology and inclusion body myositis. Neurology. https://doi.org/10.1212/WNL.0000000000201103

Article  PubMed  Google Scholar 

Winkler M, von Landenberg C, Kappes-Horn K, Neudecker S, Kornblum C, Reimann J (2021) Diagnosis and clinical development of sporadic inclusion body myositis and polymyositis with mitochondrial pathology: a single-center retrospective analysis. J Neuropathol Exp Neurol 80:1060–1067. https://doi.org/10.1093/jnen/nlab101

Article  CAS  PubMed  Google Scholar 

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955–1964. https://doi.org/10.1136/annrheumdis-2017-211468

Article  PubMed  Google Scholar 

Udd B, Stenzel W, Oldfors A, Olivé M, Romero N, Lammens M et al (2019) 1st ENMC European meeting: The EURO-NMD pathology working group Recommended Standards for Muscle Pathology Amsterdam, The Netherlands, 7 December 2018. Neuromuscul Disord 29:483–485. https://doi.org/10.1016/j.nmd.2019.03.002

Article  PubMed  Google Scholar 

Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016. Neuromuscul Disord 2018;28:87–99. https://doi.org/10.1016/j.nmd.2017.09.016.

Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347. https://doi.org/10.1056/NEJM197502132920706

Article  CAS  PubMed  Google Scholar 

Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407. https://doi.org/10.1056/NEJM197502202920807

Article  CAS  PubMed  Google Scholar 

Mammen AL, Allenbach Y, Stenzel W, Benveniste O, ENMC 239th Workshop Study Group. 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018. Neuromuscul Disord 2020;30:70–92. https://doi.org/10.1016/j.nmd.2019.10.005.

Stenzel W, Mammen AL, Gallay L, Holzer M-T, Kleefeld F, Benveniste O et al (2024) 273rd ENMC International workshop: Clinico-Sero-Morphological Classification of the Antisynthetase Syndrome, Amsterdam, The Netherlands, 27–29 October 2023. Neuromuscul Disord 2014:104453. https://doi.org/10.1016/j.nmd.2024.104453

Article  Google Scholar 

Benveniste O, Stenzel W, Allenbach Y (2016) Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 29:662–673. https://doi.org/10.1097/WCO.0000000000000376

Article  CAS  PubMed  Google Scholar 

Brady S, Squier W, Hilton-Jones D (2013) Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 84:1240–1246. https://doi.org/10.1136/jnnp-2013-305690

Article  PubMed  Google Scholar 

Shelly S, Triplett JD, Pinto MV, Milone M, Diehn FE, Zekeridou A et al (2020) Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. Brain Commun 2:fcaa181. https://doi.org/10.1093/braincomms/fcaa181

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lauletta A, de Le HL, Leonard-Louis S, Garibaldi M, Allenbach Y, Benveniste O (2025) Refining the clinical and therapeutic spectrum of granulomatous myositis from a large cohort of patients. J Neurol 272:123. https://doi.org/10.1007/s00415-024-12748-9

Article  PubMed  Google Scholar 

DiMauro S, Tanji K, Bonilla E, Pallotti F, Schon EA (2002) Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects. Muscle Nerve 26:597–607. https://doi.org/10.1002/mus.10194

Article  CAS  PubMed  Google Scholar 

Lilleker JB, Naddaf E, Saris CGJ, Schmidt J, de Visser M, Weihl CC et al (2024) 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16–18 June 2023, Hoofddorp, The Netherlands. Neuromuscul Disord 37:36–51. https://doi.org/10.1016/j.nmd.2024.03.001

Article  PubMed  Google Scholar 

Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C (1995) Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 54:581–587. https://doi.org/10.1097/00005072-199507000-00012

Article  CAS  PubMed  Google Scholar 

Nelke C, Kleefeld F, Preusse C, Ruck T, Stenzel W (2022) Inclusion body myositis and associated diseases: an argument for shared immune pathologies. Acta Neuropathol Commun 10:84. https://doi.org/10.1186/s40478-022-01389-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P et al (2002) Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain 125:1635–1645. https://doi.org/10.1093/brain/awf163

Article  PubMed  Google Scholar 

Abad C, Pinal-Fernandez I, Guillou C, Bourdenet G, Drouot L, Cosette P et al (2024) IFNγ causes mitochondrial dysfunction and oxidative stress in myositis. Nat Commun 15:5403. https://doi.org/10.1038/s41467-024-49460-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Plotz P, Miller FW et al (2019) Identification of distinctive interferon gene signatures in different types of myositis. Neurology 93:e1193–e1204. https://doi.org/10.1212/WNL.0000000000008128